+44 (0) 28 9442 2413 Click here to view Randox Chinese website Click here to view Randox French website Click here to view Randox Polish website Click here to view Randox South Korea website
Reagents

TxBCardio

With up to 25-30% of patients on lose dose aspirin therapy suffering from a lack of aspirin effect, the identification of these patients is crucial- with Randox TxBCardio, this is possible.

Randox TxBCardio is an automated assay for the evaluation of aspirin response, enabling timely intervention by clinicians with patients deemed to be displaying a sub-optimum reaction to their aspirin therapy.

Key Features and Benefits

For research use only in the USA. Not for use in diagnostic procedures in the USA.

Cardiac

The Heart-type Fatty Acid Binding Protein (H-FABP)

The Heart-type Fatty Acid Binding Protein (H-FABP) assay from Randox is a rapid, accurate immunoturbidimetric assay for the quantitative determination of H-FABP in serum and plasma. Suitable for use on the RX Series of chemistry analysers, results can be obtained in less than 14 minutes. Applications are also available for a wide range of analysers.

H-FABP is 20 times more cardiac specific than Myoglobin and is released as early as 30 minutes after an ischemic episode, providing rapid diagnosis when it is critically needed.  

Key Features and Benefits

Products

Contract Manufacturing

Product List 2014

Randox Engineering Randox accreditations